FI40096C - Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner - Google Patents

Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner

Info

Publication number
FI40096C
FI40096C FI122162A FI122162A FI40096C FI 40096 C FI40096 C FI 40096C FI 122162 A FI122162 A FI 122162A FI 122162 A FI122162 A FI 122162A FI 40096 C FI40096 C FI 40096C
Authority
FI
Finland
Prior art keywords
pharmacologiskt
förfaringssätt
diazabicyclo
octane
för framställning
Prior art date
Application number
FI122162A
Other languages
English (en)
Finnish (fi)
Other versions
FI40096B (da
Inventor
Cignarella Giorgio
Testa Emilio
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of FI40096B publication Critical patent/FI40096B/fi
Publication of FI40096C publication Critical patent/FI40096C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI122162A 1961-06-26 1962-06-25 Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner FI40096C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB23076/61A GB949088A (en) 1961-06-26 1961-06-26 Diazabicyclo-octane derivatives

Publications (2)

Publication Number Publication Date
FI40096B FI40096B (da) 1968-06-28
FI40096C true FI40096C (fi) 1968-10-10

Family

ID=10189738

Family Applications (1)

Application Number Title Priority Date Filing Date
FI122162A FI40096C (fi) 1961-06-26 1962-06-25 Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner

Country Status (6)

Country Link
BE (1) BE618813A (da)
BR (1) BR6240334D0 (da)
CH (1) CH423799A (da)
DK (1) DK105414C (da)
FI (1) FI40096C (da)
GB (1) GB949088A (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274018B (it) * 1994-02-23 1997-07-14 Riace Ets Derivati del 3,8-diazabiciclo(3.2.1.)ottano ad attivita' analgesica
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
CN101044144A (zh) 2004-11-30 2007-09-26 神经研究公司 作为胆碱能配体的新的二氮杂双环芳基衍生物
US8673920B2 (en) * 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2632465B1 (en) 2010-10-27 2015-12-30 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2632464B1 (en) 2010-10-29 2015-04-29 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
MX2014001946A (es) 2011-08-19 2014-03-27 Merck Sharp & Dohme Inhibidores del canal de potasio medularmente externo renal.
WO2013039802A1 (en) 2011-09-16 2013-03-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013062892A1 (en) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013062900A1 (en) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773351B1 (en) 2011-10-31 2017-08-23 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013066714A1 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773206B1 (en) 2011-10-31 2018-02-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2790511B1 (en) 2011-12-16 2016-09-14 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
EP2925322B1 (en) 2012-11-29 2018-10-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9573961B2 (en) 2012-12-19 2017-02-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9604998B2 (en) 2013-02-18 2017-03-28 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014150132A1 (en) 2013-03-15 2014-09-25 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2015017305A1 (en) 2013-07-31 2015-02-05 Merck Sharp & Dohme Corp Inhibitors of the renal outer medullary potassium channel
WO2016127358A1 (en) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel

Also Published As

Publication number Publication date
BE618813A (fr) 1962-10-01
BR6240334D0 (pt) 1973-05-24
FI40096B (da) 1968-06-28
GB949088A (en) 1964-02-12
DK105414C (da) 1966-09-26
CH423799A (de) 1966-11-15

Similar Documents

Publication Publication Date Title
FI40096C (fi) Förfaringssätt för framställning av farmakologiskt, t.ex. diuretiskt aktiva 3,8-diazabicyklo-£3,2,1|-oktaner
BE612258A (fr) 3-X-oxo-1,8-naphtyridines et leur préparation.
FR2165M (fr) 5-(diazacycloalkyl)-10,11-dihydrodibenzocycloheptenes.
FI37834A (fi) Anordning för framställning av tunnväggiga, på en sida öppna kärl, t.ex. bägare av i värme formbart konstämne
BE608766A (fr) Transporteurs.
DK108774C (da) Bortstuvelig mellemdækskonstruktion.
NL143394B (nl) Communicatiestelsel.
FR2259M (fr) Nouveaux médicaments diurétiques.
FR1509M (fr) Nouveau diurétique.
DK104665C (da) Luftpudefartøj.
FI34734A (fi) Stoftutmatningsapparat för utmatning av stoft från stoftavskiljare, t.ex. cyklonrenare
CA615440A (en) Benzothiadiazine-1,1-dioxides
FI40560C (fi) Förfarande för framställning av akrylfibrer
FI37822A (fi) Anordning för spånskärning av stockar, speciellt trästammar
FI35508A (fi) Sätt för framställning av järnpreparat, som intages oralt
CA612932A (en) 9-halo-.delta.4-pregnene-11-oxygenated-16,17-diol-3,20-diones
FI34339A (fi) Ytterdäck, särskilt för flygmaskiner
FI35608A (fi) Förbindelseprofil, särskilt för fönster- och dörramar
AU262959B2 (en) Double-baked, self-channelling electrode
CA620543A (en) 2-methyl-6-fluoro-1,4-pregnadienes
AU281621B2 (en) 3-substituted-13, 17-dialkyl-17-hydroxy
FR2605M (fr) 6,16-diméthyl-15-déhydro-stéroides.
CA631321A (en) 3-oxygenated allopregnane-6,11-dione compounds
GR22079B (el) Νεος τυπος καθισματος.
CA622326A (en) 6-METHYL-9.alpha.-FLUORO-11-OXYGENATED-17.alpha.-HYDROXY-4-PREGNENE-3,20-DIONES